- Home
- XPOF vs VNDA Comparison
XPOF vs VNDA Comparison
Compare XPOF & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPOF
- VNDA
- Stock Information
- Founded
- XPOF 2017
- VNDA 2002
- Country
- XPOF United States
- VNDA United States
- Employees
- XPOF N/A
- VNDA N/A
- Industry
- XPOF Services-Misc. Amusement & Recreation
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- XPOF Consumer Discretionary
- VNDA Health Care
- Exchange
- XPOF Nasdaq
- VNDA Nasdaq
- Market Cap
- XPOF 388.8M
- VNDA 270.2M
- IPO Year
- XPOF 2021
- VNDA 2006
- Fundamental
- Price
- XPOF $12.93
- VNDA $4.73
- Analyst Decision
- XPOF Buy
- VNDA Buy
- Analyst Count
- XPOF 10
- VNDA 1
- Target Price
- XPOF $16.85
- VNDA $13.00
- AVG Volume (30 Days)
- XPOF 248.5K
- VNDA 641.3K
- Earning Date
- XPOF 11-05-2024
- VNDA 11-06-2024
- Dividend Yield
- XPOF N/A
- VNDA N/A
- EPS Growth
- XPOF N/A
- VNDA N/A
- EPS
- XPOF N/A
- VNDA N/A
- Revenue
- XPOF $326,668,000.00
- VNDA $182,022,000.00
- Revenue This Year
- XPOF $0.85
- VNDA $6.70
- Revenue Next Year
- XPOF $9.33
- VNDA $51.03
- P/E Ratio
- XPOF N/A
- VNDA N/A
- Revenue Growth
- XPOF 15.41
- VNDA N/A
- 52 Week Low
- XPOF $7.40
- VNDA $3.30
- 52 Week High
- XPOF $18.95
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- XPOF 52.80
- VNDA 48.57
- Support Level
- XPOF $11.35
- VNDA $4.68
- Resistance Level
- XPOF $12.51
- VNDA $4.98
- Average True Range (ATR)
- XPOF 0.46
- VNDA 0.18
- MACD
- XPOF 0.10
- VNDA 0.05
- Stochastic Oscillator
- XPOF 90.57
- VNDA 40.00
About XPOF Xponential Fitness Inc.
Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix, a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.